Cargando…
World’s First Experience Treating TASC II C and D Tibial Occlusive Disease Using the Selution SLR Sirolimus-Eluting Balloon: Six-Month Results From the PRESTIGE Study
PURPOSE: The performance of sirolimus-coated devices has not been studied in patients with chronic limb-threatening ischemia patients. PRESTIGE aims to investigate the 6-month efficacy and safety profile of the Selution Sustained Limus Release (SLR) sirolimus-eluting balloon for treatment of TASC II...
Autores principales: | Tang, Tjun Yip, Yap, Charyl, Soon, Shereen Xue Yun, Chan, Sze Ling, Lee, QingWei Shaun, Yap, Hao Yun, Tay, Hsien Ts’ung Luke, Chong, Tze Tec |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276341/ https://www.ncbi.nlm.nih.gov/pubmed/33843364 http://dx.doi.org/10.1177/15266028211007457 |
Ejemplares similares
-
Utility of the selution SLR™ sirolimus eluting balloon to rescue failing arterio-venous fistulas – 12 month results of the ISABELLA Registry from Singapore
por: Tang, Tjun Y, et al.
Publicado: (2022) -
Intervention with selution SLR™ Agent Balloon for Endovascular Latent
Limus therapy for failing AV Fistulas (ISABELLA) Trial: Protocol for a pilot
clinical study and pre-clinical results
por: Tang, Tjun Yip, et al.
Publicado: (2021) -
One year clinical outcomes of Rutherford 6 chronic limb threatening ischemia patients undergoing lower limb endovascular revascularisation from Singapore
por: Lee, Rui En, et al.
Publicado: (2022) -
Distribution of Peripheral Arterial Disease in Patients Undergoing Endovascular Revascularization for Chronic Limb Threatening Ischaemia: Insights from the Vascular Quality Initiative in Singapore
por: Soon, Shereen X. Y., et al.
Publicado: (2021) -
Use of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit?
por: Chong, Tze Tec, et al.
Publicado: (2020)